This document discusses lung cancer and the role of the protein WDR72. It describes the two main types of lung cancer as non-small cell lung cancer (NSCLC), which accounts for 80-85% of cases, and small cell lung cancer (SCLC), which spreads faster but responds better to chemotherapy. The objective is to investigate how WDR72 influences lung cancer cell stemness and provide new treatment strategies. Methods like luciferase assays, RT-qPCR, western blot, and apoptosis assays are used to quantify protein and gene expression levels. Knocking down WDR72 expression suppresses lung cancer growth and metastasis via the AKT/HIF-1α signaling pathway, suggesting WDR72 could be a new